Last reviewed · How we verify
NCT06741046
RT for Cervical Adenocarcinoma/adenosquamous Carcinoma
trial in Uterine Neoplasms in 400 participants. Participants enrolled and being followed up; not accepting new ones.
1 June 2025
Quick facts
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 June 2014 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 June 2027 |
| Sites | 1 location across China |
Conditions studied
- Uterine Neoplasms — all drugs for Uterine Neoplasms →
- Genital Neoplasms, Female — all drugs for Genital Neoplasms, Female →
Sponsor
Peking Union Medical College Hospital
Who can join
Adults 18 to 80, female only, with Uterine Neoplasms or Genital Neoplasms, Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was to retrospectively analyze patients with cervical adenocarcinoma/adenosquamous carcinoma who had been admitted to our hospital. Approximately 500 cases of cervical adenocarcinoma were planned to be included, summarize the disease characteristics, treatment regimens, and recurrence patterns of the patients, and analyze the association between treatment regimens and recurrence patterns and prognosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Appraisal the significance of completion hysterectomy after definitive concurrent chemoradiotherapy for patients with locally advanced cervical adenocarcinoma: the ATTRACT study.
Yang XL, Zhu JW, Zhou YC, You Y, et al · · 2026 · PMID 41190353 · DOI 10.1097/js9.0000000000003549
Verify or expand the search:
- PubMed search for NCT06741046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Uterine Neoplasms
Currently open trials in the same condition.
- NCT07038369 — A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations · Phase 1 · active not recruiting
- NCT06953076 — Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study · recruiting
- NCT05242861 — Retrospective Study of Brachytherapy · recruiting
- NCT06774482 — Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms · recruiting
- NCT04579380 — Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations · Phase 2 · active not recruiting
Other Peking Union Medical College Hospital trials
Trials by the same sponsor.
- NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
- NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
- NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
- NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
- NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06741046 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06741046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing